HOME >> MEDICINE >> NEWS
Millions wasted on blood pressure tablets

Millions of dollars are being spent unnecessarily each year on treatments for high blood pressure says research published this week in BMC Health Services Research. Vast amounts could be saved if doctors prescribed thiazides, the recommended and cheapest drugs, rather than expensive alternatives.

Atle Fretheim and his colleagues from the Norwegian Directorate for Health and Social Affairs estimated the potential annual savings for six countries if thiazides were prescribed whenever there was no reason to use an alternative. The savings could be huge: Canada - US$13.8m, France - US$37.4m, Germany - US$72.2m, Norway - US$10.7m, UK - US$119.7m and US - US$433.6m.

"Our calculations are based on conservative estimates. The potential for saving is likely to be considerably higher, and may be over US$1billion per year in the US," write the researchers.

To produce these estimates, the researchers used sales, prescription and survey data to estimate the number of people in each country that were being treated for high blood pressure, and the proportion of those that were taking thiazides. The proportion varied between countries from 12% to 40%. Previously published research suggests that thiazides could be used effectively in at least 45% of all cases. Armed with this information, the researchers worked out the potential annual cost savings to health services. They calculated the costs of increasing thiazide usage to its limit, and the resulting cost reductions of other treatments, assuming these reductions would be distributed evenly across those treatments.

All clinical guidelines recommend thiazides as a first choice drug for treating uncomplicated high blood pressure. This is because no drug to treat high blood pressure has been identified as being clearly superior to the others, and the evidence that thiazides reduce the risk of stroke and heart disease is strong. Thiazides are also amongst the best tolerated drugs, and are by far
'"/>

Contact: Gemma Bradley
press@biomedcentral.com
44-207-323-0323
BioMed Central
7-Sep-2003


Page: 1 2

Related medicine news :

1. Millions who suffer from nut and milk allergies could benefit from Stanford researchers test
2. Millions of Asian Americans and Pacific Islanders at increased risk for type 2 diabetes
3. Millions turn a blind eye to dangerous driving
4. Millions of Americans are failing to get recommended health care
5. Millions of migraine sufferers could benefit from better use of medical care
6. Millions Of Americans With Glaucoma Could Save Sight With Early Detection, Treatment
7. Engineering Study For The CDC Shows How To Fight Low Childhood Immunization,Save Millions In Health Costs
8. A marker for new blood vessel formation in tumors
9. Acupuncture found to lower elevations in blood pressure
10. Diagnostic test for range of blood disorders on the horizon
11. Research suggests possible blood test for multiple sclerosis

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Millions wasted blood pressure tablets

(Date:3/5/2015)... 2015 Wimbledon Health Partners , ... echocardiogram and NCV testing, announced the addition ... Medical Officer. Dr. Artel will be responsible for medical ... WimbledonMED program and the continued growth and support of ... with Wimbledon Health Partners as a consulting physician since ...
(Date:3/5/2015)... CA (PRWEB) March 05, 2015 Altec ... workflow solutions, announced today their participation in the Houston, ... Tour 2015. The Inspire Tour will unite Sage enterprise ... share ideas about workable solutions to real-world business challenges. ... at the Crowne Plaza Houston Galleria Area on March ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 March 5, ... Safety—kicks off next week (March 8-14, 2015), children’s hospitals ... families play in making hospital stays as safe as ... of children’s hospitals—Children’s Hospitals’ Solutions for Patient Safety (SPS) ... tips for families to follow when visiting the hospital ...
(Date:3/5/2015)... T.E.N., a technology and information ... and winners Thursday evening, March 4, at the ... at the Westin Buckhead in Atlanta, GA. ... was selected as the Information Security Executive® of ... Region. Pete is an industry veteran with over ...
(Date:3/5/2015)... The MTC 5-day Fundamental Implantology Course ... from a variety of dental disciplines, to offer implant ... "From the onset we wanted this course to be ... to the excellence of the lecturers and the sheer ... more than satisfied our aims." , Unlike large-scale ...
Breaking Medicine News(10 mins):Health News:Wimbledon Health Partners Appoints Chief Medical Officer to Attain Medicare Market Share 2Health News:Wimbledon Health Partners Appoints Chief Medical Officer to Attain Medicare Market Share 3Health News:Altec Attends Sage Inspire Tour Stops in Houston and Charlotte to Showcase Sage ERP Document Management and Workflow Solution 2Health News:Altec Attends Sage Inspire Tour Stops in Houston and Charlotte to Showcase Sage ERP Document Management and Workflow Solution 3Health News:Children’s Hospitals Offer Safety Tips for Patient Families During National Patient Safety Awareness Week 2Health News:Children’s Hospitals Offer Safety Tips for Patient Families During National Patient Safety Awareness Week 3Health News:Children’s Hospitals Offer Safety Tips for Patient Families During National Patient Safety Awareness Week 4Health News:Pete Chronis of EarthLink and Jabil Claim Top Awards at ISE® Southeast 2Health News:Pete Chronis of EarthLink and Jabil Claim Top Awards at ISE® Southeast 3Health News:Pete Chronis of EarthLink and Jabil Claim Top Awards at ISE® Southeast 4Health News:MIS Global Training Center (MTC) Launches its Fundamental Implantology Course for Doctors - with a Difference 2
(Date:3/5/2015)...  ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), ... of targeted antiviral therapies, announced today that it will ... to be held March 8-11, 2015, in ... Sapirstein , Chief Executive Officer, will provide an overview ... will be available to participate in one-on-one meetings with ...
(Date:3/5/2015)... March 5, 2015 Hitachi ... generation of OASIS *    at ECR 2015 ... power will set a benchmark for patient-centric care. The ... prevent delays whilst optimizing workflow management and costs. OASIS ... and safety for imaging in Neurology, Orthopaedics, Paediatrics, Oncology, ...
(Date:3/5/2015)... , March 5, 2015  Asterias Biotherapeutics, Inc. (NYSE ... field of regenerative medicine, announced today that ... top rehabilitation hospitals for spinal cord injury and brain ... trial of AST-OPC1 (oligodendrocyte progenitor cells) in newly injured ... injury (SCI). The Phase 1/2a trial ...
Breaking Medicine Technology:ContraVir to Present at 27th Annual ROTH Conference 2Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 2Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 3Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 4
Cached News: